Colon Cancer
A Multi-center, Open-label, Randomized, Phase 2 Clinical Trial Evaluating Safety and Efficacy of FOLFIRI with Either Panitumumab or Bevacizumab as Second-line Treatment in Subjects with Metastatic Colorectal Cancer with Wild-Type KRAS tumors
Trial ID: 07141
Contact: Lisa Sherman
Phone: (281)863-6658
Learn More about this trial.
go back | new search